pentadecapeptide BPC 157

pentadecapeptide BPC 157

Model NO.:137525-51-0 Name:Pentadecapeptide Bpc 157 CAS:137525-51-0 Molecular Formula:C62h98n16o22 Molecular Weight:1419.53552 Assay:99% Appearance:White Lyophilized Powder

Description BPC 157 has a strong anti-inflammatory activity in both acute and chronic inflammation models.In fact, preliminary results in clinical trials suggest that BPC 157 may become an important therapeutic tool for the treatment of inflammatory bowel disease.BPC 157 was shown to accelerate wound healing and to have a marked angiogenic effect.In addition, it significantly facilitates the healing of bone fracture in rats.This peptide also exhibits an osteogenic effect significantly improving the healing of segmental bone defect.BPC 157 accelerates the healing of transected rat Achilles tendon and transected rat quadriceps muscle.

BPC 157 is a pentadecapeptide made up of 15 amino acids. The amino acids sequence in BPC 157 is similar to a portion of the human BPC amino acid sequence. Human BPC is found in the gastric juice. Experiments have shown that BPC 157 enhances the healing of wounds, including tendons wounds such as transected Achilles tendons of rats.

The aim of this study was to investigate the probable mechanism that BPC 157 utilizes to accelerate the healing process in an injured tendon.The results also showed that BPC 157 significantly increased the survival of cells under oxidative stress.

Furthermore, the Transwell filter migration assay showed that BPC 157 significantly increased in-vitro fibroblast migration in a dose-dependent fashion. Moreover, BPC 157 accelerated the dispersal of the fibroblasts in culture dishes in a dose-dependent manner. Appilication

Pentadecapeptide BPC 157, composed of 15 amino acids, is a partial sequence of body protection compound that is discovered in and isolated from human gastric juice.BPC 157 has a strong anti-inflammatory activity in both acute and chronic inflammation models.

In fact, preliminary results in clinical trials suggest that BPC 157 may become an important therapeutic tool for the treatment of inflammatory bowel disease. BPC 157 was shown to accelerate wound healing and to have a marked angiogenic effect.This peptide also exhibits an osteogenic effect significantly improving the healing of segmental bone defect.

This study was designed to investigate the potential mechanism of BPC 157 to enhance healing of injured tendon. The outgrowth of tendon fibroblasts from tendon explants cultured with or without BPC 157 was examined. Results showed that BPC 157 significantly accelerated the outgrowth of tendon explants.

Other peptides: Name Specification T-A001 MGF 2mg/vial T-A002 PEG MGF 2mg/vial T-A003 CJC-1295 with DAC 2mg/vial T-A004 CJC-1295 without DAC 2mg/vial T-A005 PT-141 10mg/vial T-A006 MT-1(Melanotan) 10mg/vial T-A007 MT-2 10mg/vial T-A008 GHRP-2 5mg/vial T-A008 GHRP-2 10mg/vial T-A009 GHRP-6 5mg/vial T-A009 GHRP-6 10mg/vial T-A010 Ipamorelin 2mg/vial T-A011 Hexarelin 2mg/vial T-A012 Sermorelin 2mg/vial T-A013 Oxytocin 2mg/vial T-A014 TB500 2mg/vial T-A015 pentadecapeptide BPC 157 2mg/vial T-A016 HGH 176-191 2mg/vial T-A017 Triptorelin 2mg/vial T-A018 Tesamorelin 2mg/vial T-A020 Gonadorelin 2mg/vial T-A020 Gonadorelin 10mg/vial T-A021 DSIP 2mg/vial T-A022 Selank 5mg/vial